Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Tiebout

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Developments in Biological Standardization|January 1, 1990
Tissue culture in hollow-fibre systems: implications for downstream processing and stability analysisR F Tiebout
European Journal of Immunology|May 1, 1984
Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxinR F Tiebout, E A Stricker, R Hagenaars, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
A human hybrid hybridomaR F Tiebout, F van Boxtel-Oosterhof, E A Stricker, et al.
Scandinavian Journal of Immunology|September 1, 1985
A human monoclonal IgG1 lambda anti-hepatitis B surface antibody. Production, properties, and applicationsE A Stricker, R F Tiebout, P N Lelie, et al.
Scandinavian Journal of Immunology|December 1, 1985
Xenohybridization of Epstein-Barr virus-transformed cells for the production of human monoclonal antibodiesR F Tiebout, E A Stricker, F Oosterhof, et al.
Immunology|February 1, 1987
Requirements for growth of Epstein-Barr virus-transformed cells at low cell densitiesR F Tiebout, R W Sauerwein, W G van der Meer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Developments in Biological Standardization|January 1, 1990
Tissue culture in hollow-fibre systems: implications for downstream processing and stability analysisR F Tiebout
European Journal of Immunology|May 1, 1984
Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxinR F Tiebout, E A Stricker, R Hagenaars, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
A human hybrid hybridomaR F Tiebout, F van Boxtel-Oosterhof, E A Stricker, et al.
Scandinavian Journal of Immunology|September 1, 1985
A human monoclonal IgG1 lambda anti-hepatitis B surface antibody. Production, properties, and applicationsE A Stricker, R F Tiebout, P N Lelie, et al.
Scandinavian Journal of Immunology|December 1, 1985
Xenohybridization of Epstein-Barr virus-transformed cells for the production of human monoclonal antibodiesR F Tiebout, E A Stricker, F Oosterhof, et al.
Immunology|February 1, 1987
Requirements for growth of Epstein-Barr virus-transformed cells at low cell densitiesR F Tiebout, R W Sauerwein, W G van der Meer, et al.
Pageof 1